The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAmid the accelerating integration of artificial intelligence within the healthcare sector, OneMedNet has secured a pivotal commercial milestone. According to reports, OneMedNet shares surged 33% in after-hours trading following the announcement of an $11.5 million agreement. The deal involves supplying the company's AI-ready healthcare data platform to support advanced technological development.
The rally was specifically triggered by the contract to provide the iRWD imaging data platform for training foundational AI models. Per analyst facts, the scale of this agreement is significant relative to the company's size, underscoring its growth potential in the specialized data market. Prior to the after-hours surge, the stock had already closed the regular session up 17.79% according to market data.
Regarding current price levels, authoritative closing data for ONMD is unavailable as of July 29, 2026; therefore, investors should monitor qualitative price direction and volume. While the upcoming economic calendar does not list specific catalysts for OneMedNet, broader market sentiment may be influenced by upcoming inflation data from the US and Japan scheduled for late July.